Comparative Review of Oral P2Y12 Inhibitors.

Link to article at PubMed

Related Articles

Comparative Review of Oral P2Y12 Inhibitors.

P T. 2018 Jun;43(6):352-357

Authors: Koski R, Kennedy B

Abstract
Current practice guidelines recommend dual antiplatelet therapy comprised of aspirin and a purinergic signaling receptor Y12 (P2Y12) for patients following acute coronary syndrome. This article compares the efficacy, safety, and other characteristics of the three available oral P2Y12 inhibitors-clopidogrel, prasugrel, and ticagrelor.

PMID: 29896034 [PubMed]

Leave a Reply

Your email address will not be published.